234 related articles for article (PubMed ID: 34303757)
1. Anesthetic Bladder Capacity is a Clinical Biomarker for Interstitial Cystitis/Bladder Pain Syndrome Subtypes.
Plair A; Evans RJ; Langefeld CD; Matthews CA; Badlani G; Walker SJ
Urology; 2021 Dec; 158():74-80. PubMed ID: 34303757
[TBL] [Abstract][Full Text] [Related]
2. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome.
Schachar JS; Evans RJ; Parks GE; Zambon J; Badlani G; Walker SJ
Int Urogynecol J; 2019 Nov; 30(11):1863-1870. PubMed ID: 31254048
[TBL] [Abstract][Full Text] [Related]
3. Non-bladder centric interstitial cystitis/bladder pain syndrome phenotype is significantly associated with co-occurring endometriosis.
Overholt TL; Evans RJ; Lessey BA; Matthews CA; Hines KN; Badlani G; Walker SJ
Can J Urol; 2020 Jun; 27(3):10257-10262. PubMed ID: 32544050
[TBL] [Abstract][Full Text] [Related]
4. Bladder Hydrodistention Does Not Result in a Significant Change in Bladder Capacity for Interstitial Cystitis/Bladder Pain Syndrome Patients.
Walker SJ; Plair A; Hemal K; Langefeld CD; Matthews C; Badlani G; Zambon J; Heath H; Evans RJ
Urology; 2019 Oct; 132():81-86. PubMed ID: 31299328
[TBL] [Abstract][Full Text] [Related]
5. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
[TBL] [Abstract][Full Text] [Related]
6. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome.
Kirk PS; Santiago-Lastra Y; Qin Y; Stoffel JT; Clemens JQ; Cameron AP
Neurourol Urodyn; 2018 Aug; 37(6):2002-2007. PubMed ID: 29566264
[TBL] [Abstract][Full Text] [Related]
7. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.
Yu WR; Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):455. PubMed ID: 33432045
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Hsu YH; Kuo HC
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.
Cheng C; Rosamilia A; Healey M
Int Urogynecol J; 2012 Oct; 23(10):1361-6. PubMed ID: 22398828
[TBL] [Abstract][Full Text] [Related]
10. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
11. Autonomic response during bladder hydrodistention reflects the severity of symptoms in patients with bladder pain syndrome/interstitial cystitis.
Kim SW; Son HS; Troya IS; Kim JY; Kim MJ; Fraser MO; Kim JH
Neurourol Urodyn; 2017 Mar; 36(3):677-682. PubMed ID: 27028369
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.
Yu WR; Chang WC; Kuo HC
Int Urol Nephrol; 2022 Sep; 54(9):2157-2165. PubMed ID: 35804206
[TBL] [Abstract][Full Text] [Related]
14. Amniotic bladder therapy: six-month follow up treating interstitial cystitis/bladder pain syndrome.
Considine J; O'Hollaren K; Radoiu C; Madan R; Liaw A; Dhar N
Can J Urol; 2024 Jun; 31(3):11898-11903. PubMed ID: 38912944
[TBL] [Abstract][Full Text] [Related]
15. Broaden Horizons: The Advancement of Interstitial Cystitis/Bladder Pain Syndrome.
Li J; Yi X; Ai J
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498919
[TBL] [Abstract][Full Text] [Related]
16. Early three-month report of amniotic bladder therapy in patients with interstitial cystitis/bladder pain syndrome.
Madan R; Radoiu C; Liaw A; Lucas S; Hamada A; Dhar N
Int Urol Nephrol; 2023 Aug; 55(8):1937-1942. PubMed ID: 37273012
[TBL] [Abstract][Full Text] [Related]
17. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
18. Risk of Urinary Tract Carcinoma among Subjects with Bladder Pain Syndrome/Interstitial Cystitis: A Nationwide Population-Based Study.
Wu MP; Luo HL; Weng SF; Ho CH; Chancellor MB; Chuang YC
Biomed Res Int; 2018; 2018():7495081. PubMed ID: 30050942
[TBL] [Abstract][Full Text] [Related]
19. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
20. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.
Rais-Bahrami S; Friedlander JI; Herati AS; Sadek MA; Ruzimovsky M; Moldwin RM
BJU Int; 2012 May; 109(9):1356-9. PubMed ID: 21883848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
